title: MiRNA profile associated with replicative senescence, extended cell culture, and ectopic telomerase expression in human foreskin fibroblasts.
abstract: Senescence is a highly regulated process that limits cellular replication by enforcing a G1 arrest in response to various stimuli. Replicative senescence occurs in response to telomeric DNA erosion, and telomerase expression can offset replicative senescence leading to immortalization of many human cells. Limited data exists regarding changes of microRNA (miRNA) expression during senescence in human cells and no reports correlate telomerase expression with regulation of senescence-related miRNAs. We used miRNA microarrays to provide a detailed account of miRNA profiles for early passage and senescent human foreskin (BJ) fibroblasts as well as early and late passage immortalized fibroblasts (BJ-hTERT) that stably express the human telomerase reverse transcriptase subunit hTERT. Selected miRNAs that were differentially expressed in senescence were assayed for expression in quiescent cells to identify miRNAs that are specifically associated with senescence-associated growth arrest. From this group of senescence-associated miRNAs, we confirmed the ability of miR-143 to induce growth arrest after ectopic expression in young fibroblasts. Remarkably, miR-143 failed to induce growth arrest in BJ-hTERT cells. Importantly, the comparison of late passage immortalized fibroblasts to senescent wild type fibroblasts reveals that miR-146a, a miRNA with a validated role in regulating the senescence associated secretory pathway, is also regulated during extended cell culture independently of senescence. The discovery that miRNA expression is impacted by expression of ectopic hTERT as well as extended passaging in immortalized fibroblasts contributes to a comprehensive understanding of the connections between telomerase expression, senescence and processes of cellular aging.
authors.affiliation: Division of Medicinal Chemistry and Natural Products, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
authors.forename: Laura N
authors.initials: LN
authors.lastname: Bonifacio
authors.forename: Michael B
authors.initials: MB
authors.lastname: Jarstfer
mesh_terms: D002453:Cell Cycle; D002460:Cell Line; D002478:Cells, Cultured; D016922:Cellular Senescence; D005347:Fibroblasts / Q000166:cytology* / Q000201:enzymology / Q000378:metabolism; D052816:Foreskin / Q000166:cytology* / Q000201:enzymology / Q000378:metabolism; D015870:Gene Expression; D006801:Humans; D008297:Male; D035683:MicroRNAs / Q000235:genetics* / Q000378:metabolism; D019098:Telomerase / Q000235:genetics* / Q000378:metabolism
chemical_list: D035683:MicroRNAs; D019098:Telomerase
references.citation: Cancer Res. 2007 Dec 1;67(23):11099-101
references.pmid: 18056431
references.citation: Nature. 2009 Jul 2;460(7251):66-72
references.pmid: 19571879
references.citation: Nat Biotechnol. 2010 Apr;28(4):341-7
references.pmid: 20351690
references.citation: J Cell Physiol. 2009 Oct;221(1):109-19
references.pmid: 19475566
references.citation: Biochim Biophys Acta. 2009 Jun;1792(6):497-505
references.pmid: 19268705
references.citation: Cell Death Differ. 2010 Feb;17(2):236-45
references.pmid: 19696787
references.citation: Nucleic Acids Res. 2008 Sep;36(16):5391-404
references.pmid: 18701644
references.citation: EMBO J. 2003 Aug 15;22(16):4212-22
references.pmid: 12912919
references.citation: Curr Atheroscler Rep. 2009 May;11(3):236-42
references.pmid: 19361356
references.citation: Genome Res. 2010 Apr;20(4):440-6
references.pmid: 20219944
references.citation: Oncogene. 2008 Oct 9;27(46):5975-87
references.pmid: 18711403
references.citation: Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14723-8
references.pmid: 9843956
references.citation: Oncol Rep. 2006 Oct;16(4):845-50
references.pmid: 16969504
references.citation: Cancer Gene Ther. 2010 Jun;17(6):398-408
references.pmid: 20094072
references.citation: Nature. 2008 Aug 7;454(7205):766-70
references.pmid: 18600261
references.citation: Am J Physiol Endocrinol Metab. 2010 Jul;299(1):E110-6
references.pmid: 20424141
references.citation: PLoS One. 2009 Jun 09;4(6):e5848
references.pmid: 19513126
references.citation: PLoS One. 2010 May 20;5(5):e10724
references.pmid: 20505758
references.citation: Biochim Biophys Acta. 2009 Apr;1792(4):341-52
references.pmid: 19419692
references.citation: Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15472-7
references.pmid: 17875987
references.citation: Aging (Albany NY). 2009 Apr;1(4):402-11
references.pmid: 20148189
references.citation: Nat Rev Cancer. 2002 Aug;2(8):627-33
references.pmid: 12154355
references.citation: Mol Cell Biol. 2005 Sep;25(18):8037-43
references.pmid: 16135795
references.citation: Genome Res. 2010 Apr;20(4):434-9
references.pmid: 20219945
references.citation: J Biol Chem. 2008 Feb 1;283(5):2654-62
references.pmid: 18048365
references.citation: Nat Cell Biol. 2009 Sep;11(9):1135-42
references.pmid: 19701195
references.citation: Nature. 2007 Jun 28;447(7148):1130-4
references.pmid: 17554337
references.citation: Nat Protoc. 2006;1(3):1112-6
references.pmid: 17406391
references.citation: Nature. 2007 Feb 8;445(7128):656-60
references.pmid: 17251933
references.citation: J Biol Chem. 2010 Mar 12;285(11):7986-94
references.pmid: 20075075
references.citation: Mol Syst Biol. 2008;4:229
references.pmid: 19034270
references.citation: Int J Oncol. 2002 Jun;20(6):1247-53
references.pmid: 12012006
references.citation: Leukemia. 2010 Feb;24(2):460-6
references.pmid: 19956200
references.citation: Proc Natl Acad Sci U S A. 2006 May 2;103(18):7024-9
references.pmid: 16641092
references.citation: Nature. 2010 Mar 18;464(7287):374-9
references.pmid: 20237562
references.citation: Mol Cell Biol. 2000 Jan;20(1):273-85
references.pmid: 10594030
references.citation: Invest Ophthalmol Vis Sci. 2010 Jun;51(6):2976-85
references.pmid: 20053980